Glioma cells express HIF-2α, whereas normal neural progenitors and glia do not [15,16], suggesting that HIF-2α is tumor-specific and may be clinically relevant as it is more prevalent in tumors and is associated with a higher grade of cancer and a lower chance of survival for patients [17]. This evidence concerns the gene EPAS1 and glioma.